Compamed 2019: BGS is very satisfied with outcome of trade fair


Compamed 2019: BGS is very satisfied with outcome of trade fair

Wiehl, 22 November 2019 – Compamed is over and Dr. Andreas Ostrowicki, Managing Director of BGS, sums up the trade fair positively. On one hand, the company was able to welcome more visitors to the BGS stand than in previous years. On the other hand, there was increasing interest in alternative sterilization methods and advice regarding second-source solutions following the ongoing critical coverage on ETO sterilization and facility shutdowns in the US market. Under the motto “Energy that changes everything”, BGS actively contributed to creating awareness for themes like validation and process integration of radiation sterilization, as well as giving advice on the related regulatory requirements.

“As leading provider of sterilization services and solutions in the area of industrial application of beta and gamma rays, Compamed is a fixed date each year for BGS,” comments Dr. Andreas Ostrowicki. “The trade fair has high priority for us as a platform to exchange views and ideas with industry representatives and business partners. Despite sustained growth in the industry, the mood among medical technology companies was slightly subdued. One of the main reasons for this is the transition period of the EU Medical Device Regulation which will soon be expiring, combined with the ensuing uncertainty of marketing medical devices.” Many manufacturers fear they will not be able to place their devices on the market in a timely manner due to longer evaluation procedures. Central themes of concern in the industry were also the question of ensuring the necessary sterilization capacities commensurate with market growth, as well as establishing second sources for sterilization.

Sterilization of medical devices: Attention shifts to reducing failure risks

“The talks at the trade fair showed that the demand for double qualifications and back-up solutions for manufacturers of medical devices is becoming increasing relevant,” explained Ostrowicki. “In the context of risk assessment, every manufacturer should ask himself what would happen if there was a shutdown in the plant commissioned with the sterilization services. The most recent cases in the US show that longer shutdowns not only result in severe financial losses, but may in certain circumstances also lead to considerable supply gaps on the market; creating a second source is therefore absolutely advisable. Here, it was necessary to examine in each case whether the device in question at the existing service provider could be qualified for a second facility, whether contracts should be concluded with an additional provider, or whether a qualification for another method of sterilization was the best prevention to forestall failure risks. BGS has been following the principle of ‘redundancy’ for years now. This means that each of the three locations of the company is able to take over the processes of the other locations, thus increasing the reliability in the production.

You will find further information about radiation sterilization of medical devices and consumables for laboratories and biotechnology, amongst other things, here.










Professional article on the topic “Radiation crosslinking of films“ in the specialist magazine Kunststoffe international

Radiation crosslinking has long been used in the production of injection moulded parts. Radiation crosslinking of films, on the other hand, offers hitherto untapped potential for new appplications in the thermoforming of filled materials.

The following research results obtained at the Chair of Polymer Technology in Erlangen, Germany, together with BGS Beta-Gamma-Service, show among other things that the process window during thermoforming of filled films can be significantly widened by radiation crosslinking the semi-finished film articles.

You can download the complete article here as a PDF file.

(Kunststoffe international 10/2019, Authors: Lisa-Marie Wittmann, Dr. Dirk Fischer, Prof. Dr.-Ing Dietmar Drummer)


Compamed 2019: Radiation sterilization by BGS meets cutting edge medical technology

When it comes to sterile products for highly sensitive working areas, BGS is indispensable. Therefore, Germany’s leading provider in the industrial sterilization of medical products and lab diagnostics amongst other things is, with the help of its beta and gamma rays, once again firmly established at the Compamed in Düsseldorf. From November 18 – 21, 2019, BGS will provide information in Hall 08B, Stand 8BK16 about the capacity expansion that is being realised in Bruchsal with the reconstruction of the gamma facility; it will also provide advice to manufacturers of medical products concerning validation issues.

“In view of the medical-technical progress and the demographic development in the next years, the medical technology sector is and will remain an extremely successful growth and labour market,” comments Dr. Andreas Ostrowicki. “Without doubt, the demand for health care services and thus for medical products will continue to increase worldwide. According to estimates of the Federal Ministry of Health, there are already approximately 400,000 different medical products at present. Needless to say, the corresponding sterilization capacities have to keep up with this strong growth. BGS already invested in the expansion of facilities at a very early stage and is optimally equipped to support the market growth of the next years,”Ostrowicki continues to explain.

With the commissioning of the new gamma radiation facility, the company was already able to expand capacities for its customers to 80,000 palettes of sterile goods per year. In total, BGS operates two gamma plants and eight electron accelerators at three locations in Germany (Wiehl, Bruchsal, Saal). In these plants, medical products such as syringes, cannulas, catheters, and joint prostheses can be directly sterilized in the packaging within the shortest time and are ready for immediate use afterwards.

Based on the projected increase of sterile medical products, the topics of double qualification and back-up solutions for manufacturers of medical products will become even more significant in the future according to managing director Ostrowicki. “In the context of risk assessment, every manufacturer should ask himself what would happen if there was a shutdown in the plant commissioned with the sterilization services. We, at BGS, have been following up on the “principle of redundancy” for years. For example, each of our three locations is in a position to assume the processes of the other locations, by means of which the failure safety in production can be significantly increased,” explains Dr. Andreas Ostrowicki. Given this fact, the company once again regards itself as a solution provider at the Compamed this year and is available to answer the questions of manufacturers amongst others, giving them advice about issues relating to validation.

About the Compamed:

The Compamed trade fair in Düsseldorf is the international specialist trade fair for the medical supply industry and product development. In two trade fair halls with exhibition space of over 13,000 sqm, more than 750 exhibitors from 40 countries are expected to participate in 2019. Amongst the focus areas at the trade fair are high-tech solutions, raw materials and precursors, structural elements, components and sub-products for medical devices, technical equipment and technologies for producing medical devices, packaging and services, micro systematics, and nanotechnology as well as contract manufacturing “Electronic Manufacturing Services” (EMS), and complex OEM partnerships. In addition, international speakers and leading experts will participate in forums that present current trends in medical technology. The Compamed takes place at the same time as the Medica – the world’s largest medical trade fair. More information about the Compamed is available at






K Trade Fair 2019: BGS provides information about new applications for radiation crosslinked plastics at the world’s largest trade fair for plastics and rubber

The developments in the mobility sector are increasingly placing more complex demands on plastics: The shift towards electrical drive technologies results in the fact that plastics, in addition to their good electrical properties, high non-inflammability and higher continuous operating temperatures, must also have a high chemical resistance against electrolytes and coolants. Moreover, there are high mechanical requirements for strengths, stiffnesses and abrasion due to the necessity for weight reduction. Crosslinking of technical thermoplastics through electron beams provides an alternative to the use of metallic materials and costly high-performance plastics. BGS experts will explain the role of radiation crosslinked plastics for future mobility concepts in Hall 8A / D47 at the K Trade Fair in Düsseldorf from October 16 – October 23, 2019.

“This year, we are not only providing information about radiation crosslinking in general and thus the refinement of various types of plastics using beta and gamma rays”, explains Dr. Andreas Ostrowicki, Managing Director of BGS.  “The focus is primarily on the potential that our technology brings about for electro mobility and light construction. Here, amongst other things, we see the potential in the field of energy distribution, storage or production of energy in batteries or fuel cells, but also for the use of thermoplastic composite materials and/or organic sheets in light construction.

Through radiation crosslinking, technical plastics receive the mechanical, thermal and chemical properties of high-performance plastics. After that, the products prove themselves for use under conditions which they would normally not withstand otherwise. Among the customers of the radiation expert that has been active since 1981 are well-known manufacturers from the electrical technology, automotive industry as well as building technology and mechanical engineering sectors.

Meet BGS at the K 2019! Via this link to our trade fair calendar, you can arrange your desired time slot with one of our radiation crosslinking experts.

About the K Trade Fair

The K is the world’s largest trade fair for the plastics and rubber industry, gathering the most important providers of plastics and rubber machines, raw materials and auxiliaries as well as semi-finished products, technical parts and reinforced plastic products in one place. The K is complemented by the special show “Plastics Shape the Future”, where current topics are discussed such as packaging waste and climate change on one hand as well as preservation of natural resources, energy efficiency and recycling management on the other hand. On the eight days of the trade fair, 3,000 exhibitors and more than 200,000 visitors from all over the world are expected to attend. More information about the K can be found at

Excellent innovative strength and innovative achievements: BGS is TOP 100 Innovator

In the 26th edition of the innovation competition TOP 100, BGS Beta-Gamma-Service GmbH & Co. KG has secured its position among the best:  At the awards ceremony held on June 28 in the Frankfurt Jahrhunderthalle, the company was officially honoured for its innovative strength by Ranga Yogeshwar, the mentor of the competition, and Professor Dr. Nikolaus Franke, the scientific leader of the contest. On the basis of a scientific classification, TOP 100 assesses the innovation management of small and medium-sized enterprises and the innovative accomplishments that emerge from this. In the independent selection process, BGS convinced the jury especially in the category “innovative measures to support top management” as well as with its external orientation.The company with currently 180 employees fits smoothly into the ranks of the innovation leaders of Germany’s small and medium-sized enterprises.

“We are very pleased about the award and consider it a confirmation of our work”, comments Dr. Andreas Ostrowicki, Managing Director of BGS. “At our company, innovative strength is not only reflected in our open-mindedness towards innovative ideas, but in particular, in the ongoing development of solution ideas for our customers and the continuous research of new application areas for our services.” 

In addition to the sterilization of medical devices amongst other things, the Top Innovator, founded in Wiehl near Cologne in 1981, has specialised in the processing of plastics for electrical technology, the automotive industry and mechanical engineering. Radiation crosslinking makes inexpensive commodity plastics more robust, heat-proof and resistant against abrasion and corrosive chemicals – the process is comparable to the tempering of metals. In this way, metallic materials can be replaced by plastics without using expensive high-performance plastics – a technology where Dr. Ostrowicki sees great potential in lightweight construction, for example in the automotive industry. Meanwhile, the company operates two gamma radiation plants and eight electron accelerators at its locations in Wiehl, Bruchsal and Saal a. d. Donau, and is Germany’s leading service provider for the treatment of products with accelerated electrons (beta rays) and gamma rays.

About the TOP 100 Competition

Since 1993, compamedia GmbH has awarded the TOP 100 seal of approval for outstanding innovative strength and above-average innovation achievements to small and medium-sized enterprises. Professor Dr. Nikolaus Franke has been head of the scientific management since 2002. Dr. Franke is the founder and director of the Institute for Entrepreneurship and Innovation at the Vienna University of Economics and Business Administration. Mentor of TOP 100 is the science journalist Ranga Yogeshwar. Project partners are the Fraunhofer Society for the Promotion of Applied Research and the German Association for Small and Medium-sized Businesses (BVMW). As media partners, manager magazin, impulse and W&V support the comparisons between the companies. More information at

BGS Managing Director Dr. Andreas Ostrowicki (left) and Stefan Semmel, Director of Processes and Technology (right) with TOP 100-Mentor Ranga Yogeshwar. © KD Busch / compamedia

Event note: BGS at IMRP19 (April 1 – 5, 2019)

“Where Business and Science Connect”: Under this motto, the International Irradiation Association (iia) has invited the players in the irradiation industry to its 19th industry get-together, the International Meeting on Radiation Processing (IMRP). Organised in intervals of 2 to 3 years, this major international event is returning to Europe in 2019: Strasbourg will host the IMRP event from April 1 – 5, 2019. In workshops and talks, researchers, developers and entrepreneurs will present and discuss trends and new opportunities in the sterilization technology and radiation crosslinking.

BGS will be represented at IMRP19 with three talks on the following topics:

  • Monday, April 1, 2019:
    “Building a gamma irradiator in times of homeland security experiences from Germany”
    Dr. Andreas Ostrowicki, Managing Director
  • Tuesday, April 2, 2019
    “New Opportunities in Radiation Crosslinking”
    Dr. Andreas Ostrowicki, Managing Director
  • Wednesday, April 3, 2019:
    “Cutting-edge technologies for irradiation crosslinking and sterilization in industrial processes”
    Dr. Dirk Fischer, Head of Application Development

In addition, visitors to IMRP19 have the possibility to register for a tour of the BGS plant in Bruchsal. Amongst other things, participants await an insight into the production processes of the world’s most modern gamma radiation plant. The guided tour begins on Friday, April 5 at 8:30 a.m. in Strasbourg and ends about 1:00 p.m. in Bruchsal.

You will find more detailed information about IMRP19 at:







Complex and flexible at the same time

The company BGS, established in 1981 and headquartered in Wiehl near Cologne, covers two major areas of activity: Radiation sterilization and refinement of materials. With its other branches in Saal an der Donau and Bruchsal, the radiation specialist is represented at three locations in Germany. In an interview with our editorial team, Dr. Andreas Ostrowicki, Managing Director of BGS, provides more details. Read more


Radiation sterilisation firm expands in the UK

BGS Beta-Gamma-Service, the German market leader for radiation sterilization, is set to expand its activities in the UK and will promote its services for the first time at Health GB Manchester from 30 April to 2 May. “The UK market for medical devices is the third largest in Europe and has a significant demand for high-quality sterilization services”, says Dr Andreas Ostrowicki, the company’s CEO.

BGS: Cooperation with Nordion for new gamma radiation plant

Expansion of sterilization capacities in Bruchsal

Wiehl/Ottawa, May 12, 2016: BGS Beta-Gamma-Service GmbH (BGS) is investing in a new gamma radiation plant in Bruchsal, drawing upon the expertise of Nordion Inc. of Canada. BGS has previously cooperated with the Canadian manufacturer of cobalt-60 and gamma irradiators on the first gamma plant at BGS headquarters in Wiehl 20 years ago. BGS and Nordion have now developed a flexible and efficient gamma plant specifically designed to meet the requirements of BGS and the Bruchsal location.

This new gamma radiation plant means an expansion of capacities for BGS – in particular to meet growing demand from the medical technology and biotech industries in the field of sterilization. Delivery and installation of the new plant is scheduled for Q1 2017, with the start of operation in mid-2017. The medium-sized, family-run company is once again relying on Nordion technology for the new plant. BGS purchased its gamma radiation plant in Wiehl from the Canadian experts in 1997, continuously developing it to meet the company’s requirements. Nordion has also been providing BGS with the cobalt-60 required for the plant for many years. “We congratulate BGS on this important expansion project in the field of gamma radiation services in Germany and are proud to be a part of this project,” says Eric Beers, Sr. Director of Sales and Marketing at Nordion.

Increased demand and sustainable expansion strategy

At maximum utilization, the new gamma radiation plant in Bruchsal has an annual capacity of 80,000 pallets. It was specifically designed based on the experience of both companies to meet BGS’ requirements. The plant is currently in the approval phase and, as things currently stand, should be completed as scheduled. BGS is investing €14 million in the new plant. “For the medical technology and biotech industries – which are particularly significant to Baden-Württemberg as well as to the whole of Germany – having high-quality sterilization services in sufficient capacity is extremely important,” explains Dr. Andreas Ostrowicki, Managing Director of BGS. “The new plant enables us to respond to the rise in demand from our regional customers and further pursue sustainable expansion.”

With gamma radiation technology, pathogenic germs, mold and spores are destroyed without chemical residues, enabling safe, quick and gentle sterilization of medical products, biotech products and pharmaceutical primary packaging. This also applies to packaging in other sectors such as the foodstuffs industry and to raw materials in the fields of pharmaceuticals and cosmetics. In order to ensure safe consumption, a broad range of imported consumer goods is irradiated to eliminate harmful germs.

About BGS Beta-Gamma-Service GmbH & Co. KG

BGS is one of the leading service providers in the field of industrial applications of beta and gamma radiation for sterilization and radiation crosslinking. With beta and gamma rays, pathogenic germs are destroyed quickly, safely and in a way that is environmentally friendly. As an industry pioneer, the medium-sized, family-run company has contributed to the development of what have become established methods since 1981. BGS operates one gamma radiation plant and eight electron accelerators at three locations (Wiehl, Bruchsal, Saal). The company employs more than 145 people and is the largest company of its kind in Germany.